cathepsin G



cathepsin G

I1II1I2II2G3GG3G4GG4R5RR5E6EE6S7SS7R8RR8P9PP9H10HH10S11SS11R12RR12P13PP13Y14YY14M15MM15A16AA16Y17YY17L18LL18Q19QQ19I20II20Q21QQ21S22SS22P23PP23A24AA24G25GG25Q26QQ26S27SS27R28RR28C29CC29G30GG30G31GG31F32FF32L33LL33V34VV34R35RR35E36EE36D37DD37F38FF38V39VV39L40LL40T41TT41A42AA42A43AA43H44HH44C45CC45W46WW46G47GG47... and 188 more residue(s)...... and 188 more residue(s)

SMILES None
InChIKey None
Sequence IIGGRESRPHSRPYMAYLQIQSPAGQSRCGGFLVREDFVLTAAHCWGSNINVTLGAHNIQRRENTQQHITARRAIRHPQYNQRTIQNDIMLLQLSRRVRRNRNVNPVALPRAQEGLRPGTLCTVAGWGRVSMRRGTDTLREVQLRVQRDRQCLRIFGSYDPRRQICVGDRRERKAAFKGDSGGPLLCNNVAHGIVSYGKSSGVPPEVFTRVSSFLPWIRTTMRSFKLLDQMETPL

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

cathepsin G

I1II1I2II2G3GG3G4GG4R5RR5E6EE6S7SS7R8RR8P9PP9H10HH10S11SS11R12RR12P13PP13Y14YY14M15MM15A16AA16Y17YY17L18LL18Q19QQ19I20II20Q21QQ21S22SS22P23PP23A24AA24G25GG25Q26QQ26S27SS27R28RR28C29CC29G30GG30G31GG31F32FF32L33LL33V34VV34R35RR35E36EE36D37DD37F38FF38V39VV39L40LL40T41TT41A42AA42A43AA43H44HH44C45CC45W46WW46G47GG47... and 188 more residue(s)...... and 188 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.